 Jonathan Roach
Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biliary Atresia | 6 | 2022 | 185 | 1.890 |
Why?
| | Specialties, Surgical | 2 | 2022 | 71 | 1.360 |
Why?
| | Liver Transplantation | 5 | 2023 | 830 | 0.880 |
Why?
| | Surgical Oncology | 4 | 2023 | 18 | 0.800 |
Why?
| | Portoenterostomy, Hepatic | 3 | 2022 | 53 | 0.750 |
Why?
| | Bile Acids and Salts | 1 | 2020 | 172 | 0.670 |
Why?
| | Medical Errors | 1 | 2019 | 84 | 0.620 |
Why?
| | Cholestasis | 1 | 2020 | 225 | 0.580 |
Why?
| | Carcinoma, Hepatocellular | 3 | 2023 | 224 | 0.550 |
Why?
| | Kidney Neoplasms | 4 | 2023 | 326 | 0.550 |
Why?
| | Appendectomy | 3 | 2023 | 60 | 0.550 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 241 | 0.530 |
Why?
| | Patient Safety | 1 | 2019 | 276 | 0.530 |
Why?
| | Surgeons | 1 | 2019 | 238 | 0.500 |
Why?
| | Accidents | 1 | 2014 | 40 | 0.470 |
Why?
| | Appendicitis | 2 | 2023 | 108 | 0.470 |
Why?
| | Liver Neoplasms | 3 | 2023 | 521 | 0.470 |
Why?
| | MicroRNAs | 1 | 2020 | 607 | 0.470 |
Why?
| | Digestive System Diseases | 1 | 2013 | 23 | 0.440 |
Why?
| | Choledocholithiasis | 2 | 2023 | 14 | 0.440 |
Why?
| | Gallstones | 2 | 2023 | 28 | 0.440 |
Why?
| | Tissue and Organ Harvesting | 1 | 2013 | 69 | 0.430 |
Why?
| | Cholecystectomy, Laparoscopic | 2 | 2023 | 45 | 0.430 |
Why?
| | Abdomen | 1 | 2013 | 104 | 0.430 |
Why?
| | Hepatoblastoma | 2 | 2023 | 25 | 0.420 |
Why?
| | Child Abuse | 2 | 2014 | 455 | 0.420 |
Why?
| | Internship and Residency | 1 | 2022 | 951 | 0.410 |
Why?
| | Postoperative Complications | 3 | 2023 | 2161 | 0.410 |
Why?
| | Kidney Failure, Chronic | 1 | 2017 | 490 | 0.400 |
Why?
| | Pediatrics | 1 | 2019 | 986 | 0.380 |
Why?
| | Kidney Transplantation | 1 | 2017 | 558 | 0.380 |
Why?
| | Organ Transplantation | 1 | 2013 | 161 | 0.370 |
Why?
| | Tissue Donors | 1 | 2013 | 331 | 0.370 |
Why?
| | Child | 21 | 2023 | 18489 | 0.360 |
Why?
| | Inflammation | 1 | 2020 | 2499 | 0.350 |
Why?
| | Brain Injuries | 1 | 2014 | 451 | 0.340 |
Why?
| | Wilms Tumor | 2 | 2022 | 66 | 0.340 |
Why?
| | Bile Ducts | 2 | 2020 | 73 | 0.330 |
Why?
| | Blood Substitutes | 1 | 2009 | 27 | 0.320 |
Why?
| | Heme Oxygenase-1 | 1 | 2009 | 53 | 0.320 |
Why?
| | Abdominal Abscess | 1 | 2007 | 23 | 0.300 |
Why?
| | Cellulitis | 1 | 2007 | 46 | 0.290 |
Why?
| | Drainage | 1 | 2007 | 151 | 0.280 |
Why?
| | Hemoglobins | 1 | 2009 | 312 | 0.280 |
Why?
| | Cytokines | 2 | 2018 | 1853 | 0.280 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2392 | 0.270 |
Why?
| | Infant | 10 | 2022 | 7979 | 0.260 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 826 | 0.260 |
Why?
| | Humans | 31 | 2023 | 115589 | 0.250 |
Why?
| | Retrospective Studies | 15 | 2023 | 12608 | 0.230 |
Why?
| | Appendiceal Neoplasms | 1 | 2023 | 14 | 0.220 |
Why?
| | Laparoscopy | 2 | 2023 | 400 | 0.220 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2023 | 4 | 0.220 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2023 | 15 | 0.210 |
Why?
| | Neuroendocrine Tumors | 1 | 2023 | 83 | 0.210 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2022 | 25 | 0.200 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2022 | 27 | 0.200 |
Why?
| | Nephrectomy | 2 | 2022 | 150 | 0.190 |
Why?
| | Infant, Newborn | 5 | 2022 | 5077 | 0.190 |
Why?
| | CD79 Antigens | 1 | 2020 | 16 | 0.180 |
Why?
| | Thoracic Wall | 1 | 2020 | 15 | 0.180 |
Why?
| | Thoracic Neoplasms | 1 | 2020 | 33 | 0.180 |
Why?
| | Short Bowel Syndrome | 1 | 2020 | 19 | 0.180 |
Why?
| | Cell Line | 2 | 2020 | 2651 | 0.180 |
Why?
| | Hepatocytes | 1 | 2020 | 197 | 0.170 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 89 | 0.170 |
Why?
| | Sarcoma | 1 | 2020 | 137 | 0.160 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 4665 | 0.160 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 195 | 0.160 |
Why?
| | Membrane Glycoproteins | 1 | 2020 | 431 | 0.150 |
Why?
| | Scoliosis | 1 | 2020 | 181 | 0.150 |
Why?
| | Child, Preschool | 7 | 2022 | 9133 | 0.150 |
Why?
| | Job Satisfaction | 1 | 2019 | 170 | 0.150 |
Why?
| | Critical Pathways | 1 | 2018 | 75 | 0.150 |
Why?
| | Postoperative Care | 1 | 2018 | 222 | 0.140 |
Why?
| | Carrier Proteins | 1 | 2020 | 701 | 0.140 |
Why?
| | Perioperative Care | 1 | 2017 | 126 | 0.130 |
Why?
| | Liver | 2 | 2020 | 1690 | 0.130 |
Why?
| | Disease Models, Animal | 3 | 2020 | 3580 | 0.120 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 783 | 0.120 |
Why?
| | Adolescent | 10 | 2023 | 17890 | 0.120 |
Why?
| | Child Advocacy | 1 | 2014 | 32 | 0.120 |
Why?
| | Mice, Knockout | 1 | 2020 | 2604 | 0.120 |
Why?
| | Choledochal Cyst | 1 | 2013 | 17 | 0.110 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2013 | 49 | 0.110 |
Why?
| | Patient Selection | 1 | 2017 | 654 | 0.110 |
Why?
| | B-Lymphocytes | 1 | 2018 | 773 | 0.110 |
Why?
| | Treatment Outcome | 4 | 2023 | 9159 | 0.110 |
Why?
| | Bilirubin | 2 | 2023 | 91 | 0.110 |
Why?
| | Craniocerebral Trauma | 1 | 2014 | 129 | 0.110 |
Why?
| | Forecasting | 1 | 2014 | 333 | 0.100 |
Why?
| | Mice | 3 | 2020 | 15052 | 0.100 |
Why?
| | Preoperative Care | 1 | 2013 | 318 | 0.100 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2353 | 0.090 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 2 | 2023 | 182 | 0.090 |
Why?
| | Time Factors | 3 | 2018 | 6165 | 0.090 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1357 | 0.090 |
Why?
| | Protoporphyrins | 1 | 2009 | 17 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2022 | 2207 | 0.080 |
Why?
| | Length of Stay | 2 | 2018 | 958 | 0.080 |
Why?
| | Enzyme Induction | 1 | 2009 | 85 | 0.080 |
Why?
| | Neoplasm Staging | 2 | 2023 | 1178 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 111 | 0.080 |
Why?
| | Transcription Factor RelA | 1 | 2009 | 83 | 0.080 |
Why?
| | Colorado | 2 | 2014 | 4113 | 0.080 |
Why?
| | Gelsolin | 1 | 2007 | 9 | 0.080 |
Why?
| | Intestinal Perforation | 1 | 2007 | 38 | 0.070 |
Why?
| | Lymph | 1 | 2007 | 40 | 0.070 |
Why?
| | Animals | 4 | 2020 | 32102 | 0.070 |
Why?
| | Male | 9 | 2023 | 55949 | 0.070 |
Why?
| | Registries | 1 | 2014 | 1770 | 0.070 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 863 | 0.070 |
Why?
| | Cell Nucleus | 1 | 2009 | 553 | 0.070 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 757 | 0.060 |
Why?
| | Female | 8 | 2023 | 59913 | 0.060 |
Why?
| | Shock, Hemorrhagic | 1 | 2007 | 193 | 0.060 |
Why?
| | Combined Modality Therapy | 1 | 2007 | 1127 | 0.060 |
Why?
| | Recurrent Laryngeal Nerve | 1 | 2023 | 2 | 0.050 |
Why?
| | Aspartate Aminotransferases | 1 | 2023 | 87 | 0.050 |
Why?
| | Common Bile Duct | 1 | 2023 | 14 | 0.050 |
Why?
| | Lipase | 1 | 2023 | 66 | 0.050 |
Why?
| | Nephrons | 1 | 2022 | 16 | 0.050 |
Why?
| | Monitoring, Intraoperative | 1 | 2023 | 39 | 0.050 |
Why?
| | United States | 2 | 2023 | 12295 | 0.050 |
Why?
| | Thyroidectomy | 1 | 2023 | 52 | 0.050 |
Why?
| | Alanine Transaminase | 1 | 2023 | 141 | 0.050 |
Why?
| | Patient Readmission | 1 | 2007 | 609 | 0.050 |
Why?
| | Methylene Blue | 1 | 2022 | 23 | 0.050 |
Why?
| | Lymph Node Excision | 1 | 2023 | 141 | 0.050 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2022 | 40 | 0.050 |
Why?
| | Universities | 1 | 2003 | 340 | 0.050 |
Why?
| | Acute Disease | 1 | 2023 | 914 | 0.050 |
Why?
| | Risk-Taking | 1 | 2003 | 332 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2023 | 423 | 0.040 |
Why?
| | Pain, Postoperative | 1 | 2022 | 195 | 0.040 |
Why?
| | Markov Chains | 1 | 2020 | 114 | 0.040 |
Why?
| | Graft Survival | 1 | 2022 | 480 | 0.040 |
Why?
| | Sexual Behavior | 1 | 2003 | 440 | 0.040 |
Why?
| | Students | 1 | 2003 | 502 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2007 | 1483 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 273 | 0.040 |
Why?
| | Prevalence | 1 | 2023 | 2264 | 0.040 |
Why?
| | Adaptive Immunity | 1 | 2018 | 157 | 0.040 |
Why?
| | Spleen | 1 | 2018 | 492 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 795 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 780 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 390 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 344 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 526 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1168 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2003 | 1198 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1083 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1219 | 0.030 |
Why?
| | Quality Improvement | 1 | 2022 | 958 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1642 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2013 | 54 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 1 | 2022 | 1180 | 0.030 |
Why?
| | Morbidity | 1 | 2014 | 278 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 1138 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1856 | 0.030 |
Why?
| | Age Factors | 1 | 2018 | 2907 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 6264 | 0.020 |
Why?
| | Survival Rate | 1 | 2014 | 1650 | 0.020 |
Why?
| | Quality of Life | 1 | 2020 | 2385 | 0.020 |
Why?
| | Mesentery | 1 | 2007 | 53 | 0.020 |
Why?
| | Fluid Therapy | 1 | 2007 | 122 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 324 | 0.020 |
Why?
| | Actins | 1 | 2007 | 383 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2013 | 4440 | 0.020 |
Why?
| | Adult | 2 | 2023 | 30719 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2007 | 645 | 0.010 |
Why?
| | Aged | 1 | 2022 | 19250 | 0.010 |
Why?
| | Midwestern United States | 1 | 2003 | 39 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 10470 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2262 | 0.010 |
Why?
| | Contraception | 1 | 2003 | 118 | 0.010 |
Why?
| | Proteomics | 1 | 2007 | 859 | 0.010 |
Why?
| | Sexually Transmitted Diseases | 1 | 2003 | 154 | 0.010 |
Why?
| | School Health Services | 1 | 2003 | 206 | 0.010 |
Why?
| | Data Collection | 1 | 2003 | 636 | 0.010 |
Why?
| | Rats | 1 | 2007 | 5034 | 0.010 |
Why?
|
|
Roach's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|